Bollywood actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff have received show-cause notices from the Maharashtra Food and Drug Administration (FDA).
over their involvement in an advertisement for Vimal Elaichi. The regulator is examining whether the advertisement indirectly promotes Vimal Pan Masala, which is prohibited in Maharashtra.
The action has renewed the debate over celebrity endorsements and surrogate advertising, particularly when a legal product carries the branding of a product associated with tobacco or pan masala.
The actors have been asked to respond to the notices. The FDA has also sought information about their endorsement arrangements and the advertising campaign.
Important clarification: The regulator involved in this case is the Maharashtra Food and Drug Administration, not the US Food and Drug Administration.
Why Did the Maharashtra FDA Issue Notices?
The controversy centres on advertisements for Vimal Elaichi, a cardamom product promoted using the Vimal brand.
The Maharashtra FDA believes that the advertisement may function as surrogate advertising for Vimal Pan Masala. In such advertising, a company promotes a legal product while using branding that consumers may associate with another restricted or prohibited product.
According to reports, the regulator is examining whether the campaign maintains the visibility and recognition of the Vimal pan masala brand even though the advertised product is presented as elaichi.
The issue has become particularly sensitive because pan masala and tobacco-related products face strict restrictions in Maharashtra.
What Is Surrogate Advertising?
Surrogate advertising is a marketing practice in which a brand associated with a restricted product is promoted through another product or service.
For example, a company may advertise an apparently legal product such as cardamom, soda or another mouth-freshener while maintaining the same brand identity used for a tobacco or pan masala product.
Regulators can examine such campaigns to determine whether the advertisement is genuinely promoting the legal product or indirectly keeping the prohibited product’s brand visible.
In this case, the Maharashtra FDA says the Vimal Elaichi advertisement requires scrutiny because of its connection with the wider Vimal brand.
What Has the FDA Asked the Actors to Do?
The notices reportedly ask the three actors to explain their involvement in the advertisement and provide details concerning their endorsement arrangements.
They have also been asked to stop promoting the advertisement and remove related promotional material from their social media accounts, according to reports. The actors were given 15 days to respond.
The notices are show-cause notices. Therefore, they do not mean that the actors have already been found guilty or fined.
The regulator will consider the responses before deciding what further action, if any, should be taken.
Why Are Shah Rukh Khan, Ajay Devgn and Tiger Shroff Involved?
All three actors have appeared in advertisements connected with the Vimal brand.
Their celebrity status has made the campaign particularly visible. Celebrity endorsements can give products a significant amount of public attention, especially when advertisements feature popular Bollywood stars.
The FDA’s action therefore raises a broader question about the responsibility of celebrities when they endorse products that may have links to restricted or controversial categories.
The regulator’s investigation is focused on whether the particular advertisement violates applicable food-safety and advertising rules.
Maharashtra’s Wider Crackdown
The notices form part of a wider enforcement campaign by Maharashtra’s FDA.
FDA Commissioner Tukaram Mundhe has defended the action and said the crackdown will not be limited to celebrities. The department is also examining advertisements and products for other potential violations, including misleading claims.
Mundhe has stressed that action can be taken against different parties involved in a violation, rather than focusing only on famous personalities.
The campaign has attracted considerable attention because several high-profile Bollywood actors have been associated with advertisements for pan masala or related products over the years.
Previous Celebrity Controversies
Celebrity endorsements of pan masala and related brands have generated controversy in India for years.
Actors often argue that they are promoting a specific legal product, such as elaichi, rather than tobacco or pan masala. However, critics argue that the branding can still create strong associations with the wider product line.
The latest FDA action has brought the debate back into the spotlight.
Past comments by Ajay Devgn and Shah Rukh Khan about celebrity endorsements have also resurfaced following the notices.
No Final Penalty Has Been Announced
It is important to distinguish between a regulatory notice and a final enforcement decision.
At this stage, the Maharashtra FDA has sought explanations from the actors. The agency will review the responses before determining whether further proceedings or penalties are justified.
Therefore, claims that the actors have already been fined should be avoided unless the regulator announces such action.
The actors’ responses could also provide more information about the nature of their contracts and their understanding of the advertised product.
What Could Happen Next?
The next stage will depend on the responses submitted by the three actors and the findings of the Maharashtra FDA.
If the regulator determines that the advertisement violated applicable provisions, further action could follow. If the actors provide explanations that satisfy the authorities, the matter could develop differently.
The advertising company and other parties connected with the campaign could also face scrutiny.
The case could eventually influence how celebrities and companies approach advertisements for products linked to restricted categories.
Impact on Celebrity Advertising
The controversy could have a wider impact on India’s advertising industry.
Brands frequently use Bollywood stars because celebrity recognition can help create trust and visibility.
However, regulators are increasingly examining whether such campaigns comply with consumer-protection and food-safety requirements.
Celebrities may also face greater pressure to conduct due diligence before signing endorsement agreements.
For advertising agencies, the case is another reminder that a campaign can face regulatory scrutiny even when the product being advertised is technically legal.
Conclusion
The FDA notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff have placed celebrity endorsements and surrogate advertising under renewed scrutiny. Maharashtra’s FDA alleges that the Vimal Elaichi advertisement could indirectly promote a pan masala brand associated with a prohibited product.
The three actors have been asked to explain their involvement, while the regulator has sought further information about the advertising campaign.
No final finding of wrongdoing has been announced against the actors at this stage. The matter will depend on the responses received and the FDA’s subsequent investigation.
Read Also | Jharkhand Government Cancels JSSC-CGL Exam After Student Protests
Leave a comment